Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann Gils

Showing results (21-30 of 162) with videos related to

Pageof 17
Sort By:
Methods in Enzymology|June 21, 2011
Use of mouse models to study plasminogen activator inhibitor-1Paul J Declerck, Ann Gils, Bart De Taeye
Therapeutic Drug Monitoring|April 6, 2017
Current Practice of Therapeutic Drug Monitoring of Biopharmaceuticals in Psoriasis PatientsCaroline Hermans, Pedro Herranz, Siegfried Segaert, et al.
Thrombosis and Haemostasis|November 16, 2004
The story of the serpin plasminogen activator inhibitor 1: is there any need for another mutant?Bart De Taeye, Ann Gils, Paul J Declerck
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 18, 2015
Identification of an inflammatory bowel disease patient with a deep vein thrombosis and an altered clot lysis profileLize Bollen, Joke Wuyts, Séverine Vermeire, et al.
Thrombosis and Haemostasis|July 3, 2009
Comparative study of inhibitory antibody derivatives towards thrombin activatable fibrinolysis inhibitorJan Develter, Maarten Dewilde, Ann Gils, et al.
Thrombosis and Haemostasis|July 24, 2003
Elucidation of the epitope of a latency-inducing antibody: identification of a new molecular target for PAI-1 inhibitionDominik Naessens, Ann Gils, Griet Compernolle, et al.
Thrombosis Research|July 18, 2012
The Biochemistry, Physiology and Pathological roles of PAI-1 and the requirements for PAI-1 inhibition in vivoBritt Van De Craen, Paul J Declerck, Ann Gils
Drug Testing and Analysis|March 19, 2016
Validation of a sample pretreatment protocol to convert a drug-sensitive into a drug-tolerant anti-infliximab antibody immunoassayThomas Van Stappen, Els Brouwers, Séverine Vermeire, et al.
Clinical Science (London, England : 1979)|April 20, 2017
The association between etanercept serum concentration and psoriasis severity is highly age-dependentIris Detrez, Kristel Van Steen, Siegfried Segaert, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 10, 2012
Glycosylation influences the stability of human plasminogen activator inhibitor-1Britt Van De Craen, Paul J Declerck, Ann Gils
Pageof 17

Showing results (21-30 of 162) with videos related to

Sort By:
Pageof 17
Methods in Enzymology|June 21, 2011
Use of mouse models to study plasminogen activator inhibitor-1Paul J Declerck, Ann Gils, Bart De Taeye
Therapeutic Drug Monitoring|April 6, 2017
Current Practice of Therapeutic Drug Monitoring of Biopharmaceuticals in Psoriasis PatientsCaroline Hermans, Pedro Herranz, Siegfried Segaert, et al.
Thrombosis and Haemostasis|November 16, 2004
The story of the serpin plasminogen activator inhibitor 1: is there any need for another mutant?Bart De Taeye, Ann Gils, Paul J Declerck
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 18, 2015
Identification of an inflammatory bowel disease patient with a deep vein thrombosis and an altered clot lysis profileLize Bollen, Joke Wuyts, Séverine Vermeire, et al.
Thrombosis and Haemostasis|July 3, 2009
Comparative study of inhibitory antibody derivatives towards thrombin activatable fibrinolysis inhibitorJan Develter, Maarten Dewilde, Ann Gils, et al.
Thrombosis and Haemostasis|July 24, 2003
Elucidation of the epitope of a latency-inducing antibody: identification of a new molecular target for PAI-1 inhibitionDominik Naessens, Ann Gils, Griet Compernolle, et al.
Thrombosis Research|July 18, 2012
The Biochemistry, Physiology and Pathological roles of PAI-1 and the requirements for PAI-1 inhibition in vivoBritt Van De Craen, Paul J Declerck, Ann Gils
Drug Testing and Analysis|March 19, 2016
Validation of a sample pretreatment protocol to convert a drug-sensitive into a drug-tolerant anti-infliximab antibody immunoassayThomas Van Stappen, Els Brouwers, Séverine Vermeire, et al.
Clinical Science (London, England : 1979)|April 20, 2017
The association between etanercept serum concentration and psoriasis severity is highly age-dependentIris Detrez, Kristel Van Steen, Siegfried Segaert, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 10, 2012
Glycosylation influences the stability of human plasminogen activator inhibitor-1Britt Van De Craen, Paul J Declerck, Ann Gils
Pageof 17